Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Steatohepatitis Stories

2008-12-08 08:21:27

Obesity is becoming one of the most common causes of liver disease in the nation. A popular surgery may resolve the dangerous disease and its cause. A recent study shows bariatric surgery, a popular and effective weight loss method for morbidly obese individuals, improves or completely resolves complications associated with nonalcoholic fatty liver disease (NAFLD) in a majority of patients. Of patients with steatosis, or fat accumulation in the liver cells, 91.6 experienced improvement or...

2008-11-03 15:00:06

Enzo Biochem, Inc. (NYSE:ENZ) reported today that recent work supported by Enzo will be presented at the Liver Conference(R), sponsored by the American Society for the Study of Liver Diseases (ASSLD), detailing research advances in understanding Natural Killer cells (NKT cells) -- lymphocytes that play a major role in immune surveillance and are involved in important processes such as autoimmunity and cancer. The research presented focuses on the following key areas involving NKT...

2008-10-27 09:00:12

SAN FRANCISCO, Oct. 27 /PRNewswire/ -- Nonalcoholic steatohepatitis (NASH) is strongly associated with obesity, and there is no approved medical therapy for this chronic progressive liver disease. Researchers tested the effects of weight reduction using a state-of-the-art lifestyle intervention program. To do so, 31 overweight or obese patients with NASH were randomized into two groups. Subjects in the first group were put on a lifestyle intervention program consisting of diet, exercise, and...

2008-10-20 06:00:22

NOVATO, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (BULLETIN BOARD: RPTP) , today announced the initiation of patient dosing in a Phase 2a clinical trial, in collaboration with the University of California, San Diego ("UCSD"), to evaluate cysteamine bitartrate ("cysteamine") in adolescents diagnosed with Non-alcoholic Steatohepatitis ("NASH"). NASH, a progressive form of liver disease that accounts for approximately 10% of newly...

2008-10-14 15:00:26

SAN FRANCISCO, Oct. 14 /PRNewswire/ -- AASLD President Arthur J. McCullough, MD, will host a press conference on the first full day of presentations at the Liver Meeting(R), the annual meeting of the American Association for the Study of Liver Diseases. Dr. McCullough will highlight individual studies and themes from the almost 1600 abstracts to be presented at this year's meeting from the leading researchers in the field. Topics will include pilot studies and clinical trials for hepatitis...

2008-08-15 00:00:10

Italian researchers said a genetic mutation may be increase the risk of steatohepatitis, also known as non- alcoholic fatty liver disease. A team of Italian, British and U.S. researchers found that inflamed livers show larger amounts of the switch protein KLF6 that regulates various biological processes, ANSA reported Thursday. The findings are published in the journal Gastroenterology. Antonio Grieco of Catholic University in Rome said people who suffer from the disease have livers...

2005-06-03 20:06:53

Currently, no medical treatment exists for nonalcoholic steatohepatitis (NASH), inflammation of the liver associated with the accumulation of fat in the liver. Recent studies indicate that NASH can result in scarring of the liver in up to 40 percent of people with the disease and cirrhosis (irreversible, advanced scarring of the liver) in approximately 25 percent of people with NASH. Researchers at Northwestern Memorial Hospital have launched a clinical trial to see if Pentoxifylline, a drug...